source
- Roche says its late-stage pipeline is full, sees growth through 2030Roche's CEO Thomas Schinecker told analysts that the company has 19 investigational medicines that could launch by 2030, indicating a robust late-stage pipeline. He added that the depth of the pip…
- FDA peptide panel faces clash as Ebola outbreak kills over 1,000 and vaccine options remain limitedThe FDA is holding a two‑day panel on peptide therapeutics, and observers anticipate heated debate among regulators and industry. The African CDC reports the fastest‑growing Ebola outbreak, with m…